Literature DB >> 27476099

Health Care Costs for Adults With Congenital Heart Disease in the United States 2002 to 2012.

David A Briston1, Elisa A Bradley2, Aarthi Sabanayagam3, Ali N Zaidi4.   

Abstract

More adults than children with congenital heart disease (CHD) are alive today. Few studies have evaluated adult congenital heart disease (ACHD) health care utilization in the United States. Data from the National Inpatient Sample from 2002 to 2012, using International Classification of Diseases, Ninth Revision, codes for moderate and complex CHD were analyzed. Hospital discharges, total billed and reimbursed amounts, length of stay, and gender/age disparities were evaluated. There was an increase in CHD discharges (moderate CHD: 4,742 vs 6,545; severe CHD: 807 vs 1,115) and total billed and reimbursed dollar amounts across all CHD (billed: $2.7 vs $7.0 billion, 155% increase; reimbursed: $1.3 vs $2.3 billion, 99% increase) and in the ACHD subgroup (billed: $543 million vs $1.5 billion, 178% increase; reimbursed: $221 vs $433 million, 95% increase). Women comprised more discharges in 2002 but not in 2012 (men:women, 2002: 6,503 vs 7,805; 2012: 7,715 vs 7,200, p = 0.39). Gender-based billed amounts followed similar trends (2002: $263 vs $280 million; 2012: $845 vs $662 million, p = 0.006) as did reimbursements (2002: $108 vs $114 million; 2012: $243 vs $190 million, p = 0.008). All age subgroups demonstrated increased health care expenditures, including the >44 versus 18- to 44-year-old age subgroup (billed: $618 vs $347 million, p <0.001; reimbursed: $136 vs $75 million, p <0.001). Our results reveal increased ACHD billed and reimbursed amounts and hospital discharges with a shift in gender-based ACHD hospitalizations: men now account for more hospitalizations in the United States. In conclusion, increased health care expenditure in older patients with ACHD is likely to increase further as health care system use and costs continue to grow.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27476099     DOI: 10.1016/j.amjcard.2016.05.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Hospital resource utilization and presence of advance directives at the end of life for adults with congenital heart disease.

Authors:  Jill M Steiner; James N Kirkpatrick; Susan R Heckbert; James Sibley; James A Fausto; Ruth A Engelberg; J Randall Curtis
Journal:  Congenit Heart Dis       Date:  2018-09-19       Impact factor: 2.007

Review 2.  Management of Heart Failure in Adult Congenital Heart Disease.

Authors:  Aarthi Sabanayagam; Omer Cavus; Jordan Williams; Elisa Bradley
Journal:  Heart Fail Clin       Date:  2018-08-20       Impact factor: 3.179

Review 3.  Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults.

Authors:  Aihua Liu; Gerhard-Paul Diller; Philip Moons; Curt J Daniels; Kathy J Jenkins; Ariane Marelli
Journal:  Nat Rev Cardiol       Date:  2022-08-31       Impact factor: 49.421

4.  HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Authors:  Juan Wang; Xiao-Qing Hu; Yu-Han Guo; Jian-Yun Gu; Jia-Hong Xu; Yan-Jie Li; Ning Li; Xiao-Xiao Yang; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

5.  The Safety and Efficacy of Transcatheter Pulmonary Valve Replacement Combined with Electrophysiology Procedures.

Authors:  Omar Abu-Anza; Luis Ochoa; Daniel McLennan; Prashob Porayette; Jennifer R Maldonado; Ian H Law; Osamah Aldoss
Journal:  Pediatr Cardiol       Date:  2020-10-13       Impact factor: 1.655

6.  Inpatient admissions and costs for adolescents and young adults with congenital heart defects in New York, 2009-2013.

Authors:  Wan-Hsiang Hsu; Kristin M Sommerhalter; Claire E McGarry; Sherry L Farr; Karrie F Downing; George K Lui; Ali N Zaidi; Daphne T Hsu; Alissa R Van Zutphen
Journal:  Birth Defects Res       Date:  2020-09-29       Impact factor: 2.661

7.  A Randomized Clinical Trial Demonstrating Feasibility and Preliminary Efficacy of a Videoconference-Delivered Physical Activity Lifestyle Intervention Among Adolescents With a Congenital Heart Defect.

Authors:  Jamie L Jackson; Kristen R Fox; Joseph R Rausch; Taylor N Swenski; Steven P Neville; Noelle C Marousis; Christina X Korth; Clifford L Cua; Vidu Garg; Kathryn Vannatta
Journal:  Ann Behav Med       Date:  2022-07-12

8.  Illness Identity: A Novel Predictor for Healthcare Use in Adults With Congenital Heart Disease.

Authors:  Liesbet Van Bulck; Eva Goossens; Koen Luyckx; Leen Oris; Silke Apers; Philip Moons
Journal:  J Am Heart Assoc       Date:  2018-05-22       Impact factor: 5.501

9.  Ambulatory Health Care Service Use and Costs Among Commercially Insured US Adults With Congenital Heart Disease.

Authors:  Anushree Agarwal; Eric Vittinghoff; Janet J Myers; R Adams Dudley; Abigail Khan; Anitha John; Gregory M Marcus
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  Association of Insurance Status With Emergent Versus Nonemergent Hospital Encounters Among Adults With Congenital Heart Disease.

Authors:  Anushree Agarwal; Michelle Gurvitz; Janet Myers; Sarthak Jain; Abigail M Khan; Gregory Nah; Ian S Harris; Peter Kouretas; Gregory M Marcus
Journal:  J Am Heart Assoc       Date:  2021-09-25       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.